SCHEMBL6180751

SCHEMBL6180751

CC(CCCCCCCCCCCC(C)(c1ccccc1)C(O)O)(C(=O)O)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.38
HIF1A Q16665 1/20 0.38
CYP1A2 P05177 2/20 0.37
CYP2D6 P10635 2/20 0.36
ACACB O00763 1/20 0.36
ACACA Q13085 1/20 0.36
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
DRD3 P35462 3/20 0.35
OPRM1 P35372 2/20 0.35
DRD2 P14416 1/20 0.35
DRD4 P21917 1/20 0.35
LMNA P02545 3/20 0.35
KCNH2 Q12809 2/20 0.35
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
KIF11 P52732 5/20 0.34
KDM4E B2RXH2 1/20 0.34
CTDSP1 Q9GZU7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6180234 1.00 CYP2C19 (0.38) CYP2C19HIF1ACYP1A2CYP2D6ACACB
SCHEMBL10264471 0.83 ACACB (0.56) CYP2C19HIF1ACYP1A2CYP2D6ACACB
SCHEMBL12094471 0.81 ACACB (0.53) CYP2C19HIF1ACYP1A2CYP2D6ACACB
SCHEMBL6179995 0.81 ACACB (0.47) CYP2C19HIF1ACYP1A2CYP2D6ACACB
SCHEMBL29456058 0.81 GAA (0.44) CYP2C19HIF1AKIF11
SCHEMBL29456136 0.81 GAA (0.44) CYP2C19HIF1AKIF11
SCHEMBL3242856 0.81 GAA (0.44) CYP2C19HIF1AKIF11
SCHEMBL6344599 0.81 GAA (0.44) CYP2C19HIF1AKIF11
SCHEMBL4003489 0.80 CYP2C19 (0.44) CYP2C19HIF1ACYP1A2CYP2D6MAPT
SCHEMBL8416402 0.80 SIGMAR1 (0.37) CYP2C19HIF1ADRD3OPRM1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1597223-A2 HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics Inc. (US) 2005-11-23 EP disclosed
WO-2004067489-A2 HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2004-08-12 WO disclosed